Skip to main content

Table 2 Cox regression models for the association between the SHR and mortality

From: The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018

 

Quantiles of the SHR

 

Q1

Q2

Q3

Q4

P for trend

All-cause mortality

     

Number of deaths

510

332

280

416

 

Model 1 h (95% CI) P-value

1

0.70 (0.57, 0.85) < 0.001

0.60 (0.52, 0.70) < 0.001

0.89 (0.74, 10.7) 0.226

< 0.001

Model 2 h (95% CI) P-value

1

0.80 (0.67, 0.96) 0.017

0.82 (0.71, 0.96) 0.012

1.24 (1.03, 1.49) 0.026

< 0.001

Model 3 h (95% CI) P-value

1

0.83 (0.70, 0.99) 0.037

0.85 (0.74, 0.99) 0.038

1.30 (1.08, 1.57) 0.006

< 0.001

CVD mortality

     

Number of deaths

150

93

69

98

 

Model 1 h (95% CI) P-value

1

0.74 (0.50, 1.08) 0.117

0.47 (0.32, 0.69) < 0.001

0.67 (0.50, 0.91) 0.009

< 0.001

Model 2 h (95% CI) P-value

1

0.86 (0.60, 1.23) 0.406

0.66 (0.45, 0.96) 0.032

0.94 (0.71, 1.25) 0.665

0.052

Model 3 h (95% CI) P-value

1

0.88 (0.62, 1.25) 0.489

0.68 (0.46, 0.99) 0.049

0.95 (0.72, 1.25) 0.693

0.096

  1. BMI body mass index; CI confidence interval; HR hazard ratio; TG triglyceride; SHR stress hyperglycemia ratio.
  2. Model 1: no covariates were adjusted for
  3. Model 2: Adjusted for age, sex and race
  4. Model 3: Adjusted for age, sex, race, BMI, smoking status, alcohol use, hypertension, coronary heart disease, chronic kidney disease, anemia, and TG